[1]苏永健,陈梦丽,李嘉铃,等.YTHDF基因DNA甲基化与乙肝疫苗低/无免疫应答水平关系研究[J].陕西医学杂志,2022,51(9):1076-1080,1085.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.007]
 SU Yongjian,CHEN Mengli,LI Jialing,et al.Relationship between DNA methylation of YTHDF gene and low/no immune response level of hepatitis B vaccine[J].,2022,51(9):1076-1080,1085.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.007]
点击复制

YTHDF基因DNA甲基化与乙肝疫苗低/无免疫应答水平关系研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年9期
页码:
1076-1080,1085
栏目:
临床研究
出版日期:
2022-09-05

文章信息/Info

Title:
Relationship between DNA methylation of YTHDF gene and low/no immune response level of hepatitis B vaccine
作者:
苏永健12陈梦丽1李嘉铃12张家玮12赵文文12陈钦艳3胡莉萍3王 超4李 海12董柏青12
(1.广西中医药大学公共卫生与管理学院流行病学教研室,广西 南宁 530200; 2.广西中医药大学广西高发传染病中西医结合转化医学重点实验室,广西 南宁 530200; 3.广西壮族自治区疾病预防控制中心广西病毒性肝炎防治研究重点实验室,广西 南宁 530029; 4.广西中医药大学基础医学院生物化学与分子生物学教研室,广西 南宁 530200)
Author(s):
SU YongjianCHEN MengliLI JialingZHANG JiaweiZHAO WenwenCHEN QinyanHU LipingWANG ChaoLI HaiDONG Baiqing
(Department of Epidemiology,School of Public Health and Management,Guangxi University of Chinese Medicine,Nanning 530200,China)
关键词:
YTHDF基因 DNA甲基化 乙肝疫苗 免疫应答水平 N6甲基腺苷 表观遗传学
Keywords:
YTHDF gene DNA methylation Hepatitis B vaccine Level of immune response N6-methyladenosine Epigenetics
分类号:
R 512.62
DOI:
DOI:10.3969/j.issn.1000-7377.2022.09.007
文献标志码:
A
摘要:
目的:从表观遗传角度探究N6-甲基腺苷(m6A)修饰相关的YTHDF基因DNA甲基化与乙肝疫苗接种者免疫低/无免疫应答水平的关系。方法:收集263例汉族儿童为研究对象。对儿童的外周血进行乙肝血清标志物检测,将乙型肝炎表面抗体(anti-HBs)浓度<100 mIU/ml者纳入病例组,将anti-HBs≥100 mIU/ml 者纳入对照组。使用Methyl Target技术检测YTHDF基因位点的DNA 甲基化水平,分析YTHDF基因81个位点 CpG DNA甲基化水平与乙肝疫苗免疫应答水平的关系。结果:病例组纳入104例,对照组纳入159例,两组年龄和性别分布比较差异无统计学意义(均P>0.05)。病例组YTHDF1_1基因23位点、YTHDF1_2基因69位点与YTHDF1_2基因140位点甲基化水平均高于对照组(均P<0.05)。多因素非条件Logistic回归分析表明,YTHDF1_1基因23位点和YTHDF1_2基因140位点甲基化水平可能是乙肝疫苗低/无免疫应答的危险因素,而YTHDF1_2基因69位点和YTHDF2_1基因28位点甲基化水平可能是乙肝疫苗低/无免疫应答的保护因素(均P<0.05)。结论:YTHDF1_1基因23位点和YTHDF1_2基因140位点甲基化水平可能是乙肝疫苗低/无免疫应答的危险因素,YTHDF1_2基因69位点和YTHDF2_1基因28位点甲基化水平可能是乙肝疫苗低/无免疫应答的保护因素。
Abstract:
Objective:To explore the relationship between DNA methylation of YTHDF gene associated with N6-methyladenosine(m6A)modification and low/no immune response in hepatitis B vaccine recipients from the epigenetic point of view.Methods:A total of 263 Han nationality children were collected.Hepatitis B serum markers were detected in children's peripheral blood.The children with hepatitis B surface antibody(anti-HBs)concentrations <100 mIU/ml were included in the case group and those with anti-HBs ≥100 mIU/ml were included in the control group.Methyl Target was used to detect DNA methylation levels at the YTHDF gene locus and to analyze the relationship between CpG DNA methylation levels at 81 locus of the YTHDF gene and the level of immune response to hepatitis B vaccine.Results:There were 104 cases in the case group and 159 cases in the control group.There was no significant difference in age and sex distribution between the two groups(all P>0.05).The methylation levels at locus 23 of YTHDF1_1 gene,locus 69 of YTHDF1_2 gene and locus 140 of YTHDF1_2 gene in the case group were higher than those in the control group(all P<0.05).Multivariate unconditional Logistic regression analysis showed that methylation levels at locus 23 of YTHDF1_1 gene and locus 140 of YTHDF1_2 gene may be risk factors for low/no immune response to hepatitis B vaccine,and methylation levels at locus 69 of YTHDF1_2 gene and locus 28 of YTHDF2_1 gene may be protective factors for low/no immune response to hepatitis B vaccine(all P<0.05).Conclusion:Methylation levels at locus 23 of THDF1_1 gene and locus 140 of YTHDF1_2 gene may be risk factors for low/no immune response to hepatitis B vaccine,while the methylation levels at locus 69 of YTHDF1_2 gene and locus 28 of YTHDF2_1 gene may be protective factors for low/no immune response to hepatitis B vaccine.

参考文献/References:

[1] Liang X,Bi S,Yang W,et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J].Vaccine,2009,27(47):6550-6557.
[2] Cui F,Shen L,Li L,et al.Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy,China[J].Emerging Infectious Diseases,2017,23(5):765-772.
[3] Liu J,Liang W,Jing W,et al.Countdown to 2030:Eliminating hepatitis B disease,China[J].Bulletin of the World Health Organization,2019,97(3):230-238.
[4] 闫永平,张维璐,苏海霞,等.我国乙型病毒性肝炎防治研究新进展和面临的挑战[J].中国热带医学,2019,19(10):916-921.
[5] Hhler T,Reuss E,Evers N,et al.Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus:A vaccination study in twins[J].The Lancet,2002,360(9338):991-995.
[6] Greenberg MVC,Bourchis D.The diverse roles of DNA methylation in mammalian development and disease[J].Nature Reviews Molecular Cell Biology,2019,20(6314):590-607.
[7] Kaminsky ZA,Tang T,Wang SC,et al.DNA methylation profiles in monozygotic and dizygotic twins[J].Nature Genetics,2009,41(2):240-245.
[8] 邹菊红,黄艳娜,蒋钦杨.RNA N6-腺苷酸甲基化修饰及其生物学功能[J].中国畜牧兽医,2021,48(4):1196-1203.
[9] Chen M,Wei L,Law CT,et al.RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2[J].Hepatology,2018,67(6):2254-2270.
[10] Zhao X,Chen Y,Mao Q,et al.Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma[J].Cancer Biomark,2018,21(4):859-868.
[11] Hou J,Zhang H,Liu J,et al.YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma[J].Mol Cancer,2019,18:163.
[12] Krawczyk A,Ludwig C,Jochum C,et al.Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine[J].Vaccine,2014,32(39):5077-5082.
[13] 梁志军,李瑞娟,王素娜,等.乙肝肝硬化对外周血T细胞亚群、免疫球蛋白及补体水平的影响[J].陕西医学杂志,2017,46(12):1655-1656.
[14] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[15] 张原青,郭津生.乙型肝炎病毒促进肝细胞性肝癌发生的机制[J].中华肝脏病杂志,2016,24(2):152-156.
[16] 王 攀,赵洪林,任 凡,等.表观遗传学在恶性肿瘤发生发展和治疗中的新进展[J].中国肺癌杂志,2020,23(2):91-100.
[17] Guo Y,Li Y,Mu S,et al.Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication[J].Journal of Medical Virology,2010,81(7):1177-1183.
[18] Zheng DL,Zhang L,Cheng N,et al.Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A[J].Journal of Hepatology,2009,50(2):377-387.
[19] Zhao Q,Fan YC,Zhao J,et al.DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B[J].Journal of Viral Hepatitis,2013,20(6):430-437.
[20] 党 珊,陈 谱,张冰斐,等.乙肝相关性肝癌患者中Foxp3启动子区甲基化及其表达的研究[J].陕西医学杂志,2014,43(2):131-133.

相似文献/References:

[1]林松荣,张 磊,罗金现,等.DNA甲基化修饰在甲状腺癌中的研究进展[J].陕西医学杂志,2021,50(2):254.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.033]
 LIN Songrong,ZHANG Lei,LUO Jinxian,et al.Research progress of DNA methylation in thyroid cancer[J].,2021,50(9):254.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.033]
[2]杨 标,李 慧,吴 盈,等.胎盘组织肿瘤坏死因子-α基因表观遗传修饰与胎盘血肿患者发生早产相关性研究[J].陕西医学杂志,2025,54(2):263.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.025]
 YANG Biao,LI Hui,WU Ying,et al.Correlation between epigenetic modification of TNF-α gene in placental tissues and the occurrence of preterm birth in patients with placental hematoma[J].,2025,54(9):263.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.025]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81760604,81360443,81703283); 广西壮族自治区自然科学基金资助项目(2017GXNSFBA198086,2013GXNSFBA019194); 广西中医药大学研究生教育创新计划项目(YCSZ2020020,YCXJ2021030)
更新日期/Last Update: 2022-09-05